HB 1581-FN (2020): relative to the labeling and sale of hemp products containing CBD.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1581-FN (2020): relative to the labeling and sale of hemp products containing CBD.” Granite Record, https://graniterecord.org/bill/2020/hb1581. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1581-FN (2020): relative to the labeling and sale of hemp products containing CBD. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/hb1581
- Chicago
- Granite Record. “HB 1581-FN (2020): relative to the labeling and sale of hemp products containing CBD.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/hb1581.
- BibTeX
@misc{bill-2020-hb1581, title = {HB 1581-FN (2020): relative to the labeling and sale of hemp products containing CBD.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/hb1581}, note = {Accessed 24 Oct. 2026} }
HB 1581-FN (2020)
relative to the labeling and sale of hemp products containing CBD.
- Status: Referred for interim study
- Term: 2019-2020
- House committee: Commerce and Consumer Affairs
- Subject: Miscellaneous
The Story
It was introduced on January 8, 2020 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on February 12, 2020. The committee held a work session on February 21, 2020. The committee met in executive session on March 3, 2020 to vote on its recommendation. The committee voted unanimously, 19–0, to recommend that the House study it after the session ends, and the report was placed on the consent calendar. On March 11, 2020 the House voted to study it after the session ends on a voice vote. The committee held a work session on September 2, 2020. The committee reported back on its interim study of the bill: “Recommended for Future Legislation”, by a vote of 8 to 7.
Sponsors
- Rep. Jerry Knirk (D - Carr 3) (prime sponsor)
- Rep. Peter Bixby (D - Straf 17)
- Rep. Garrett Muscatel (D - Graf 12)
- Rep. Howard Pearl (R - Merr 26)
- Rep. William Marsh (D - Carr 8)
Hearings and Sessions
- February 12, 2020, 1:30 PM: public hearing, House Commerce and Consumer Affairs, LOB 302
- February 21, 2020, 10:00 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
- March 3, 2020, 10:30 AM: executive session, House Commerce and Consumer Affairs, LOB 302
- September 2, 2020, 2:00 PM: full committee work session, House Commerce and Consumer Affairs
Votes
- March 11, 2020, House: Refer for Interim Study — voice vote, passed
The Docket
- January 8, 2020: Introduced 01/08/2020 and referred to Commerce and Consumer Affairs
- February 12, 2020: Public Hearing: 02/12/2020 01:30 pm LOB 302
- February 21, 2020: Subcommittee Work Session: 02/21/2020 10:00 am LOB 302
- March 3, 2020: Executive Session: 03/03/2020 10:30 am LOB 302
- March 11, 2020: Committee Report: Refer for Interim Study for 03/11/2020 (Vote 19-0; CC)
- March 11, 2020: Refer for Interim Study: MA VV 03/11/2020
- September 2, 2020: Full Committee Work Session: 09/02/2020 02:00 pm Members of the public may attend using this link: : https://www.zoom.us/j/98387930737 - Executive Session to Follow
- October 29, 2020: Interim Study Report: Recommended for Future Legislation (Vote 8-7)